comparemela.com

Latest Breaking News On - Staff medical oncologist - Page 1 : comparemela.com

Treadwell Therapeutics Announces A Presentation at the 2022 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor

/PRNewswire/ Treadwell Therapeutics, a clinical-stage biotechnology company developing novel medicines for highly aggressive cancers, today announced that.

San antonioUnited statesPhilippe bedardPrincess margaret cancer centreUniversity of torontoHenryb gonzalez convention centerSan antonio breast cancer symposiumConvention centerAssociate professorStaff medical oncologistMichael tuschePhasei trialAdvanced solid tumorsNegative breast cancer expansionTreadwell therapeuticsHealth care amp hospitals

Treadwell Therapeutics Announces A Presentation at the 2021 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor

/PRNewswire/ Treadwell Therapeutics, today announced a presentation for the Company s CFI-402257 program, an oral, best-in-class TTK inhibitor, at the 2021.

Princess margaret cancer centreUniversity of torontoTreadwell therapeuticsSan antonio breast cancer symposiumPhillipe bedardAssociate professorStaff medical oncologistMichael tuscheDose escalationPharmacokinetic studyAdvanced solid

vimarsana © 2020. All Rights Reserved.